A closer look at how the Storm3 combines market intelligence, the right relationships and a sharp sense of timing to place the people the operators who drive value creation, sharpen performance and set PE-backed businesses up for a strong exit.
AI DRUG DISCOVERY · SERIES C
A CFO ahead of the raise.
A funding round was forming. A CFO already engaged through ENGAGE was approached early and appointed before the raise, with financial leadership in place at the right moment.
BIOTECH · SERIES B
A CTO who was not on the market.
MAP had followed the shortlist for two years. The appointed CTO was settled and content, and an established relationship turned a warm introduction into a decisive hire.
BIOTECH · GROWTH
A CRO who de-risked a licence.
A regulated expansion called for a Chief Risk Officer with the right jurisdictional track record. Independent referencing confirmed the fit before the offer, lowering execution risk on a critical hire.
AI DRUG DISCOVERY · SERIES C
A CFO ahead of the raise.
A funding round was forming. A CFO already engaged through ENGAGE was approached early and appointed before the raise, with financial leadership in place at the right moment.
BIOTECH · SERIES C
A CFO ahead of the raise.
A funding round was forming. A CFO already engaged through ENGAGE was approached early and appointed before the raise, with financial leadership in place at the right moment.
HealthTech recruitment and executive search. Part of PP Recruitment Holdings Limited T/A Levin.
CAPABILITIES
FUNCTIONS
INDUSTRIES
CONSUMER & DIGITAL HEALTH
HARDWARE & DEVICES
HEALTHCARE IT
SCIENCE & RESEARCH
